In obesity, where oxidative stress typically derails insulin signaling, anthocyanins’ ability to enhance PI3K/Akt activation provides a potential therapeutic intervention for glucose metabolism improvement and insulin resistance relief. This evidence concerns the gene AKT1 and obesity due to melanocortin 4 receptor deficiency.